New Skin Cancer Patch: Possible Alternative to SurgeryJune 16, 2009Nontoxic radioactive patch successfully treats skin cancer, say researchers at SNM's 56th Annual Meeting TORONTO-A new study shows that a radioactive skin patch can safely and successfully treat basal cell carcinoma, one of the most common types of skin cancers, according to researchers at the SNM's 56th Annual Meeting. The skin patch, which delivers the radioactive phosphorus-32, is nontoxic and could be an excellent alternative to surgery or radiotherapy in cases where carrying out these treatments is difficult. "While basal cell carcinoma is rarely fatal, it can be a painful and disfiguring disease," said Priyanka Gupta, a nuclear medicine technologist in the Department of Nuclear Medicine at All India Institute of Medical Sciences, New Delhi, and lead author of the study. "It's exciting to think that this patch can deliver treatment on an outpatient basis with little risk of the scarring or other complications that surgery or radiotherapy present. This study opens a new dimension not only for treating skin malignancies, but also for nuclear medicine therapy in general." Every year, approximately one million Americans are newly diagnosed with basal cell carcinoma, a type of skin cancer that forms in the epidermis, or outer layer of the skin. The cancer is not deadly in most cases, but it still must be treated to prevent spreading. The most common forms of treatment are surgery and radiotherapy. Surgery requires hospitalization, and radiotherapy involves multiple visits to a radiotherapist. Neither treatment provides a complete cure. For patients with cancers on the face, these treatments can leave permanent scarring and can be complicated to deliver, especially for cancers that are close to the eyes, nose or mouth. In 80 percent of the cases, basal cell carcinomas appear on the head or neck. The study followed eight adult patients who elected to try the patch instead of surgery or radiotherapy. All patients had basal cell carcinoma on the face, and none had cancer cells in underlying facial structures. Sealed patches containing radioactive phosphorus-32 that deliver beta radiation to the cancer site were custom-made according to the shape and size of each patient's skin cancer lesions. The patches were applied locally on the cancer sites for three hours. The patches were then reapplied to each patient's cancer sites two more times on subsequent days, each time for three hours. The treatment took about a week to administer. Three months after treatment, biopsies of all of the patients' skin cancer sites revealed no residual malignant cancer. The treatment had few adverse effects and resulted in minimal scarring. In addition, routine blood and biochemical exams did not reveal any toxicity from the radioactive patches. Phosporous-32 poses no external radiation hazards, and its limited range prevents beta radiation from reaching the bone or underlying blood vessels, thus sparing the bone and bone marrow. Society of Nuclear Medicine |
|||||||||||||||||||||
| Related Skin Cancer Current Events and Skin Cancer News Articles Adapting Space-Industry Technology to Treat Breast Cancer Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. Switching immunosuppressants reduces cancer risk in kidney Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Latest analysis confirms suboptimal vitamin D levels in millions of US children Millions of children in the United States between the ages of 1 and 11 may suffer from suboptimal levels of vitamin D, according to a large nationally representative study published in the November issue of Pediatrics, accompanied by an editorial. Geologists studying groundwater arsenic levels in India empower Bengali women, children A Kansas State University geologist and graduate student are finding that the most important tools in their fieldwork on groundwater arsenic pollution are women and children armed with pamphlets and testing kits. Melanoma treatment options 1 step closer A targeted chemotherapy for the treatment of skin cancer is one step closer, after a team of University of Alberta researchers successfully synthesized a natural substance that shows exceptional potential to specifically treat this often fatal disease. Resident physicians seldom trained in skin cancer examination Many resident physicians are not trained in skin cancer examinations, nor have they ever observed or practiced the procedure. Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. Case Western Reserve University discovers Merkel cell originates from skin, not the neural crest Case Western Reserve University School of Medicine assistant professor of pediatrics, neurosciences and otolaryngology, Stephen M. Maricich, M.D., Ph.D., and his team found that Merkel cells originate in the skin, not the neural crest lineage, as previously speculated. A potential new imaging agent for early diagnosis of most serious skin cancer Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer. U.S. needs nearly $200 million more on climate-related health research A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health. More Skin Cancer Current Events and Skin Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||